Meiji Yasuda Life Insurance Co cut its TJX Companies holdings by nearly 39% in Q4, unloading over 45,000 shares. Other ...

Airbnb’s recent Q1 results have investors double-checking their travel itineraries and their portfolios. Despite an 8% rise ...

Blue Capital Inc. made a strategic move in Q4, snagging nearly 22,000 shares of Deere & Company, making it their largest ...

Lockheed Martin had a financially explosive quarter with Benjamin Edwards Inc. boosting its stake by 5.8%—a small piece of a ...

Brevan Howard Capital Management LP dramatically increased its holdings in Regeneron Pharmaceuticals by 141.5% in the fourth ...

Caisse DE Depot ET Placement DU Quebec downsized its Starbucks holdings by 30.2%, shedding 225,000 shares worth about $47 ...

Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...

Barclays has nudged Vertex Pharmaceuticals’ price target to $499, despite a mixed bag in its Q1 performance. Vertex saw a 3% ...

Marsh & McLennan Companies continues to attract heavyweight investors, with 1248 Management LLC buying 5,107 shares worth ...

John Sorenson, Executive VP of Global Operations at Boston Scientific, sold 4,572 company shares, trimming his stake to ...

Automatic Data Processing (ADP) delivered a third-quarter surprise with revenue climbing to $5.55 billion, up 5.7% ...

KLA Corporation might not be trending on social media, but it’s got rockstar fundamentals that would make any investor fanboy ...